期刊
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
卷 34, 期 3, 页码 623-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.rdc.2008.05.004
关键词
-
类别
资金
- NIH [AG026010, AR47218, AR049059, AR050245, AR05462]
- AstraZeneca
- DonJoy
- Lilly
- Merck
- National Institutes of Health
- Pfizer
- Stryker
- Wyeth
Symptomatic osteoarthritis (OA) causes substantial physical and psychosocial disability. This article delineates the characteristic symptoms and signs associated with OA and how they can be used to make the clinical diagnosis. The predominant symptom in most patients is pain. The remainder of the article focuses on what is known about the causes of pain in OA and factors that contribute to its severity. Much has been learned during recent years, but much of this puzzle remains unexplored or inadequately understood.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据